ACTH and Low Melanocortin-2 Receptor Expression Inhibit Infantile Spasm (IS) Seizures in Prenatal Stress (PS) Exposed Rats

Authors Information
Article Notes and Dates
To Cite : Zhang Y, Yuan S, Zou L, Ding Y, He B. et al. ACTH and Low Melanocortin-2 Receptor Expression Inhibit Infantile Spasm (IS) Seizures in Prenatal Stress (PS) Exposed Rats, Iran J Pediatr. 2017 ;27(4):e8081. doi: 10.5812/ijp.8081.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Riikonen R. Recent advances in the pharmacotherapy of infantile spasms. CNS Drugs. 2014; 28(4): 279-90[DOI][PubMed]
  • 2. Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology. 2004; 62(10): 1668-81[DOI][PubMed]
  • 3. Frost JJ, Hrachovy RA. Pathogenesis of infantile spasms: a model based on developmental desynchronization. J Clin Neurophysiol. 2005; 22(1): 25-36[DOI][PubMed]
  • 4. Nagamitsu S, Matsuishi T, Yamashita Y, Shimizu T, Iwanaga R, Murakami Y, et al. Decreased cerebrospinal fluid levels of beta-endorphin and ACTH in children with infantile spasms. J Neural Transm (Vienna). 2001; 108(3): 363-71[DOI][PubMed]
  • 5. Brunson KL, Avishai-Eliner S, Baram TZ. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol. 2002; 49: 185-97[DOI][PubMed]
  • 6. Brunson KL, Khan N, Eghbal-Ahmadi M, Baram TZ. Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Ann Neurol. 2001; 49(3): 304-12[DOI][PubMed]
  • 7. Brunson KL, Eghbal-Ahmadi M, Baram TZ. How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis. Brain Dev. 2001; 23(7): 533-8[DOI][PubMed]
  • 8. Shang NX, Zou LP, Zhao JB, Zhang F, Li H. Association between prenatal stress and infantile spasms: a case-control study in China. Pediatr Neurol. 2010; 42(3): 181-6[DOI][PubMed]
  • 9. Velisek L, Jehle K, Asche S, Veliskova J. Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain. Ann Neurol. 2007; 61(2): 109-19[DOI][PubMed]
  • 10. Gitau R, Cameron A, Fisk NM, Glover V. Fetal exposure to maternal cortisol. Lancet. 1998; 352(9129): 707-8[DOI][PubMed]
  • 11. de Weerth C, Buitelaar JK. Physiological stress reactivity in human pregnancy--a review. Neurosci Biobehav Rev. 2005; 29(2): 295-312[DOI][PubMed]
  • 12. Majzoub JA, Karalis KP. Placental corticotropin-releasing hormone: function and regulation. Am J Obstet Gynecol. 1999; 180(1 Pt 3)-6[DOI][PubMed]
  • 13. Metherell LA, Chan LF, Clark AJ. The genetics of ACTH resistance syndromes. Best Pract Res Clin Endocrinol Metab. 2006; 20(4): 547-60[DOI][PubMed]
  • 14. Penhoat A, Naville D, El Mourabit H, Buronfosse A, Berberoglu M, Ocal G, et al. Functional relationships between three novel homozygous mutations in the ACTH receptor gene and familial glucocorticoid deficiency. J Mol Med (Berl). 2002; 80(7): 406-11[DOI][PubMed]
  • 15. Liu ZL, He B, Fang F, Tang CY, Zou LP. Genetic polymorphisms of MC2R gene associated with responsiveness to adrenocorticotropic hormone therapy in infantile spasms. Chin Med J (Engl). 2008; 121(17): 1627-32[PubMed]
  • 16. Ding YX, Zou LP, He B, Yue WH, Liu ZL, Zhang D. ACTH receptor (MC2R) promoter variants associated with infantile spasms modulate MC2R expression and responsiveness to ACTH. Pharmacogenet Genomics. 2010; 20(2): 71-6[DOI][PubMed]
  • 17. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet. 2004; 364(9447): 1773-8[DOI][PubMed]
  • 18. Riikonen R. Infantile spasms: therapy and outcome. J Child Neurol. 2004; 19(6): 401-4[DOI][PubMed]
  • 19. Schioth HB, Chhajlani V, Muceniece R, Klusa V, Wikberg JE. Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. Life Sci. 1996; 59(10): 797-801[DOI][PubMed]
  • 20. Xia Y, Wikberg JE. Localization of ACTH receptor mRNA by in situ hybridization in mouse adrenal gland. Cell Tissue Res. 1996; 286(1): 63-8[DOI][PubMed]
  • 21. Elias LL, Huebner A, Pullinger GD, Mirtella A, Clark AJ. Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype. J Clin Endocrinol Metab. 1999; 84(8): 2766-70[DOI][PubMed]
  • 22. Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev. 2004; 56(1): 1-29[DOI][PubMed]
  • 23. Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke M. ACTH-receptor expression, regulation and role in adrenocortial tumor formation. Eur J Endocrinol. 2001; 144(3): 199-206[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

Iranian Journal of Pediatrics accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check